Search results :

LMWH

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: B01AB05

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9
Dyspnoea Dyspnoea 3.3% 5.2% x x x x x x x x x
Nausea Nausea 1% - 3% 0% - 2% x x x x x x x x x
Confusional state Confusional state 2.2% 1.1% x x x x x x x x x
Feeling abnormal Confusional state 2.2% 1.1% x x x x x x x x x
Diarrhoea Diarrhoea 2.2% 1.7% x x x x x x x x x
Haemorrhage Haemorrhage 0% - 13% 0% - 3% x x x x x x x x x
Major bleed x x x x x x x x x
Haemoglobin Haemorrhage 0% - 13% 0% - 3% x x x x x x x x x
Anaemia Anaemia 0% - 16% 1% - 7% x x x x x x x x x
Oedema Oedema 1% - 2% 0% - 2% x x x x x x x x x
Ecchymosis Ecchymosis 0% - 3% x x x x x x x x x
Thrombocytopenia Thrombocytopenia postmarketing, 1.5% - 2.8% 2.8% x x x x x x x x x
Cardiac failure Cardiac failure 0.951% x x x x x x x x x
Haemorrhage intracranial Haemorrhage intracranial 0.825% x x x x x x x x x
Pneumonia Pneumonia 0.824% x x x x x x x x x
Atrial fibrillation Atrial fibrillation 0.697% x x x x x x x x x
Pulmonary oedema Pulmonary oedema 0.697% x x x x x x x x x
Body temperature increased Body temperature increased 0% - 8% 0% - 3% x x x x x x x x x
Haematuria Haematuria 0% - 2% x x x x x x x x x
Oedema peripheral Oedema peripheral 0% - 6% 0% - 3% x x x x x x x x x
Injection site haemorrhage Injection site haemorrhage 0% - 5% x x x x x x x x x
Alopecia Alopecia postmarketing x x x x x x
Eosinophilia Eosinophilia postmarketing x x x x x x
Headache Headache postmarketing x x x x x x
Haematoma Haematoma postmarketing x x x x x x x x x
Hyperkalaemia Hyperkalaemia postmarketing x x x x x x x x x
Hyperlipidaemia Hyperlipidaemia postmarketing x x x x x x x x x
Hypersensitivity Hypersensitivity postmarketing x x x x x x x x x
Hypertriglyceridaemia Hypertriglyceridaemia postmarketing x x x x x x x x x
Blood triglycerides increased Hypertriglyceridaemia postmarketing x x x x x x x x x
Inflammation Inflammation postmarketing x x x x x x x x x
Nodule Nodule postmarketing x x x x x x x x x
Osteoporosis Osteoporosis postmarketing x x x x x
Pruritus Pruritus postmarketing x x x x x x x x x
Purpura Purpura postmarketing x x x x x x x x x
Vascular purpura Purpura postmarketing x x x x x x x x x
Shock Shock postmarketing x x x x x
Thrombosis Thrombosis postmarketing x x x x x x x x x
Urticaria Urticaria postmarketing x x x x x x x x x
Vasculitis Vasculitis postmarketing x x x x x x x x x
Skin necrosis Skin necrosis postmarketing x x x x x x x x x
Skin exfoliation Skin necrosis postmarketing x x x x x x x x x
Rash pustular Vesiculobullous rash postmarketing x x x x x x x x x
Dermatitis bullous Vesiculobullous rash postmarketing x x x x x x x x x
Diabetes mellitus Diabetic postmarketing x x x x x x x x x
Anaphylactic shock Anaphylactoid reaction postmarketing x x x x x x x x x
Anaphylactoid reaction Anaphylactoid reaction postmarketing x x x x x x x x x
Paralysis Paralysis postmarketing x x x x x x x x x
Dermatitis atopic Cutaneous hypersensitivity postmarketing x x x x x x x x x
Thrombocytosis Thrombocytosis postmarketing x x x x x x x x x
Local reaction Local reaction postmarketing x x x x x x x x x
Spinal haematoma Spinal haematoma postmarketing x x x x x x x x x
Haemorrhagic anaemia Haemorrhagic anaemia postmarketing x x x x x x
Cholestatic liver injury Cholestatic liver injury postmarketing x x x x x x
Liver disorder Liver disorder x x x x x x x x x
Hepatocellular injury Liver disorder x x x x x x x x x
Foetor hepaticus Liver disorder x x x x x x x x x
Pain Pain x x x x x x x x x
Erythema Erythema x x x x x x x x x
Injection site pain Injection site pain 0% - 2% x x x x x x x x x
Aspartate aminotransferase increased Aspartate aminotransferase increased x x x x x x x x x
Alanine aminotransferase increased Alanine aminotransferase increased x x x x x x x x x
Malaise Sickness x x x x x x x x x
Epidural haemorrhage Epidural haemorrhage x x x x x x x x x
Electrocardiogram ST segment elevation Electrocardiogram ST segment elevation x x x x x x x x x
Myocardial infarction Non-Q wave MI x x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ENOXAPARIN

Side effects:50
Source:FDA Structured Product Label

ENOXAPARIN

Side effects:50
Source:FDA Structured Product Label

ENOXAPARIN

Side effects:50
Source:FDA Structured Product Label

enoxaparin

Side effects:56
Source:FDA Structured Product Label

enoxaparin

Side effects:56
Source:FDA Structured Product Label

ENOXAPARIN

Side effects:57
Source:FDA Structured Product Label

enoxaparin

Side effects:57
Source:FDA Structured Product Label

enoxaparin

Side effects:57
Source:FDA Structured Product Label

enoxaparin

Side effects:57
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label